id | Study | Lib. in paper | Exposition period | Study type |
Control type |
Tags | OR 95%CI | x1/n1 x0/n0 | no cases | no exposed | ROB | Ref. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
S13888 R55950 |
Fisher - Beta-blockers (Controls unexposed, disease free), 2017 | Total anomalous pulmonary venous return | early pregnancy | case control | unexposed, disease free excluded | Adjustment: No Indications Antihypertensive: All hypertensions, any indications or not specified |
2.94 [0.58;9.33] excluded (control group) |
3/43 -/- | - | 43 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S14244 R55962 |
Fisher - Beta-blockers (Controls unexposed, sick), 2017 | Total anomalous pulmonary venous return | early pregnancy | case control | unexposed, sick | Adjustment: No Indications Antihypertensive: All hypertensions, any indications or not specified | 4.21 [0.75;15.76] | 3/43 -/- | - | 43 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total | 1 studies | 4.21 [0.92;19.30] | 0 | 43 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives |
1: Controls unexposed, sick;
Funnel plot not drawn. Less than 3 points.
Asymetry test p-value = NaN (by Egger's regression)
not enought points
Funnel plot not drawn. Less than 3 points.
excluded 13888